Home » Topics » Regulatory » Patents

Patents
RSS

Shiseido claims pyrrolidines for gastric and peptic ulcers

Oct. 27, 1998

Yamanouchi discloses 5-HT2C receptor agonists with high potency and selectivity

Oct. 27, 1998

Korean research institute develops new NMDA receptor antagonists

Oct. 27, 1998

Agents for schizophrenia from Yoshitomi typified by Y-36074

Oct. 27, 1998

Preparation and pharmaceutical formulations of nimesulide choline salt claimed by Dompe

Oct. 27, 1998

Safe and effective therapeutics for neuropathic pain in early development at Roche

Oct. 26, 1998

Benzamides with antiulcer, antisecretory and anti-H. pylori effects discovered at Shiseido

Oct. 26, 1998

Nonsteroid progesterone antagonists for cancer, gynecological disorders

Oct. 26, 1998

Beta-glucuronidase inhibitors as antitumor/antiinflammatory agents

Oct. 26, 1998

New Na+/H+ exchange inhibitors in development at HMR

Oct. 26, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...